SLC6A3 and Parkinson disease: Our results suggest that GDNF improves defective DAT glycosylation and increases the membrane distribution of DAT in PD cells, as well as yielding consistent results in the prefrontal cortex (PFC) and the ventral tegmental area (VTA) of PD mice.